Invokana Lawsuit Claim Draws Public Attention To Drug’s Possible Severe Kidney Side Effects

March 07, 2016 – – TheProductLawyers.com discusses information recently released concerning common adverse event reports which were issued to the U.S. Food and Drug Administration potentially linking new-generation, type-2 diabetes drug Invokana to serious and potentially life-threatening kidney damage risks among patients using the drug. According to the U.S. Food and Drug Administration, who receives these and other adverse event reports, over 50 have been made linking the drug to the potential development of renal impairment and kidney failure among patients. These 50 reports were from the drug’s first year on the market only.

Invokana was the first of a group of several similar drugs released to market known as SGLT2 class inhibitors. Invokana works to help type 2 diabetes patients manage their blood sugar levels by preventing the kidneys from absorbing extra glucose and then using them to remove that sugar from the body through urination. This is a process which obviously depends heavily on the kidneys and increases their day-to-day functioning significantly. Because diabetes is already difficult on the kidneys, this added stress can cause them some serious damage.

Pyelonephritis is a term for kidney infections. These infections can be life-threatening and occur when a virus or bacteria are able to enter the kidney area. They can quickly lead to the development of kidney disease or complete kidney failure, and are therefore very dangerous. Unfortunately, damage sustained to the kidneys cannot be repaired, so those who suffer from kidney failure require complete kidney transplants.

Patients using Invokana or other SGLT2 class inhibitor drugs are being asked by the FDA to remain very aware of any signs of kidney damage. These signs can include fatigue, itchy skin, nausea, appetite and weight loss, headaches, and dry patches of skin.

Invokana has also been linked to kidney problems in a report issued by The Institute for Safe Medication Practices (ISMP) in their May 2015 QuarterWatch publication. It discussed connections made by patients taking Invokana who had suffered more than 457 serious health problems within just one year’s time. 54 of these reported events discussed kidney failure or renal impairment among patients.

The attorneys of Banville Law sponsor an Invokana resource website at TheProductLawyers.com. They have become very aware of how dangerous kidney infections can be, and also understand how many patients from across the nation need effective diabetes treatments. At this time, the attorneys of Banville Law are working to assist anyone who may have used SGLT2 class inhibitor drugs and who also suffered from health problems that they believe were caused by their use of the drugs. They hope to help ensure that these patients will be given the opportunity to fully investigate their legal rights. To help those deserving seek justice, the attorneys of Banville Law are currently offering free Invokana consultations.

To ask questions, or to request additional Invokana lawsuit information, please contact the attorneys of Banville Law by calling 877-671-6480.

###

Contact TheProductLawyers.com:

Banville Law
877-671-6480
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60008535